http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EC-SP003641-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40a92325286ca98dbffa06d2c67ed064 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-00 |
| filingDate | 2000-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d61e5d1643c5d24afd1108520c900519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ea6ea00d476098bf53ee8de2a9cff0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5af36f1153a33c5f5706ef5dea07f371 |
| publicationDate | 2002-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EC-SP003641-A |
| titleOfInvention | FUSIONATED PIRROLCARBOZAMIDS; A NEW CLASS CLASS OF GABA CEREBRAL RECEIVERS |
| abstract | These are substituted pyrrolcarboxamide compounds. These compounds are highly selective inverse agonists, antagonists or agonists of GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists of GABA brain receptors. Therefore, they are useful in the diagnosis and treatment of anxiety, depression, dementia caused by Alzheimer's disease, sleep disorders and convulsives, overdose, with benzodiazepines and to improve memory. There are also pharmaceutical compounds, including packaged pharmaceutical compounds. The compounds of the invention are also useful as tests for the localization of GABA receptors in tissue samples. |
| priorityDate | 1999-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.